Pfizer BNT162b2 – 5.3.6

Pfizer BNT162b2 – 5.3.6

Cliquez sur une date ci-dessous pour consulter la version correspondante.

Vous pouvez également comparer deux versions en les sélectionnant dans les colonnes "Anciennes" et "Nouvelles", puis en cliquant sur "Comparer les versions"



Anciennes Nouveau document Créé le Auteur Actions
mars 2, 2022 à 8:09 Pr. Bösung
mars 2, 2022 à 8:07 Pr. Bösung
mars 2, 2022 à 8:06 Pr. Bösung

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports

Report Prepared by : Worldwide Safety

Pfizer

The information contained in this document is proprietary and confidential. Any disclosure, reproduction, distribution, or other dissemination of this information outside of Pfizer, its Affiliates, its Licensees, or Regulatory Agencies is strictly prohibited. Except as may be otherwise agreed to in writing, by accepting or reviewing these materials, you agree to hold such information in confidence and not to disclose it to others (except where required by applicable law), nor to use it for unauthorized purposes.

Share This

Share this post with your friends!